CompoAtlas

Golden Rules Golden Avomine Pro

Natural health product licensed in Canada

Other names
Golden Formulas Golden Avomine Pro, Seven Medallion Golden Avomine Pro
Licence holder
Golden Rules Medical Inc.
NPN or DIN-HM
80056721
Status
Active licence
Licence date
22 December 2014
Revision date
28 December 2016
Form
Capsule, dur
Route of administration
Orale
Application type
Non traditionnelle

If this product were sold in France

No point flagged by the rules we apply.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Insaponifiables d'avocat/soja

Source : Persea americana - fruit

300 mgNot calculated
Insaponifiables d'avocat/soja

Source : Glycine max - Fruit

300 mgNot calculated
Harpagophytum procumbens

Source : Racine

Extract : Matériel brut sec

Extraction ratio : 4:1

Dry plant equivalent : 200 mg

50 mgNot calculated
1,3,7-triméthylxanthine

Source : Caféine

200 mgNot calculated

Non-medicinal ingredients

Gélatine, Stéarate de magnésium, Cellulose microcristalline

PopulationAgeQuantity per servingFrequency
AdultesNot specified1 Capsule1 day

Uses authorised in Canada

Text supplied in English because no French text is available.

Help relieve joint pain associated with osteoarthritis. Helps (temporarily) to promote alertness and wakefulness, and to enhance cognitive performance. Helps (temporarily) to relieve fatigue, to promote endurance, and to enhance motor performance.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Source

Official Health Canada record, licence 80056721

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Harpagophytum procumbens
    Read the warning, when it applies and the studies cited

    DEVIL'S CLAW - HARPAGOPHYTUM

    Route of administration: Oral

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.

    Health Canada monograph dated 27 March 2026

They concern the ingredient, not this product or its dose. They do not replace medical advice.

List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).

Photograph the packaging

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

List recorded in 2016. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line